These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3726547)

  • 1. Near-total glutathione depletion and age-specific cataracts induced by buthionine sulfoximine in mice.
    Calvin HI; Medvedovsky C; Worgul BV
    Science; 1986 Aug; 233(4763):553-5. PubMed ID: 3726547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of mouse buthionine sulfoximine cataracts in vitro is inhibited by thiols or ascorbate.
    Calvin HI; Zhu G; Wu J; Banerjee U; Fu JS
    Exp Eye Res; 1997 Sep; 65(3):341-7. PubMed ID: 9299171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lens GSH depletion and electrolyte changes preceding cataracts induced by buthionine sulfoximine in suckling mice.
    Calvin HI; von Hagen S; Hess JL; Patel SA; Fu SC
    Exp Eye Res; 1992 Apr; 54(4):621-6. PubMed ID: 1623947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione ester prevents buthionine sulfoximine-induced cataracts and lens epithelial cell damage.
    Mårtensson J; Steinherz R; Jain A; Meister A
    Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8727-31. PubMed ID: 2813421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticataractogenic property of gamma-glutamylcysteine ethyl ester in an animal model of cataract.
    Ohtsu A; Kitahara S; Fujii K
    Ophthalmic Res; 1991; 23(1):51-8. PubMed ID: 1870842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-lipoic acid prevents buthionine sulfoximine-induced cataract formation in newborn rats.
    Maitra I; Serbinova E; Trischler H; Packer L
    Free Radic Biol Med; 1995 Apr; 18(4):823-9. PubMed ID: 7750805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of brain glutathione in preweanling mice by L-buthionine sulfoximine.
    Slivka A; Spina MB; Calvin HI; Cohen G
    J Neurochem; 1988 May; 50(5):1391-3. PubMed ID: 3361302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo inhibition of l-buthionine-(S,R)-sulfoximine-induced cataracts by a novel antioxidant, N-acetylcysteine amide.
    Carey JW; Pinarci EY; Penugonda S; Karacal H; Ercal N
    Free Radic Biol Med; 2011 Mar; 50(6):722-9. PubMed ID: 21172425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione depletion in tissues after administration of buthionine sulphoximine.
    Minchinton AI; Rojas A; Smith KA; Soranson JA; Shrieve DC; Jones NR; Bremner JC
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1261-4. PubMed ID: 6469748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modifications in lens protein biosynthesis signal the initiation of cataracts induced by buthionine sulfoximine in mice.
    Calvin HI; Wu JX; Viswanadhan K; Fu SC
    Exp Eye Res; 1996 Oct; 63(4):357-68. PubMed ID: 8944543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereospecific effects of R-lipoic acid on buthionine sulfoximine-induced cataract formation in newborn rats.
    Maitra I; Serbinova E; Tritschler HJ; Packer L
    Biochem Biophys Res Commun; 1996 Apr; 221(2):422-9. PubMed ID: 8619871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buthionine sulfoximine-mediated depletion of glutathione in intracranial human glioma-derived xenografts.
    Skapek SX; Colvin OM; Griffith OW; Groothuis DR; Colapinto EV; Lee Y; Hilton J; Elion GB; Bigner DD; Friedman HS
    Biochem Pharmacol; 1988 Nov; 37(22):4313-7. PubMed ID: 3196356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of melatonin on cataract formation in newborn rats: evidence for an antioxidative role for melatonin.
    Abe M; Reiter RJ; Orhii PB; Hara M; Poeggeler B
    J Pineal Res; 1994 Sep; 17(2):94-100. PubMed ID: 7869232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive modifications of mouse lens crystallins in cataracts induced by buthionine sulfoximine.
    Calvin HI; Patel SA; Zhang JP; Li MY; Fu SC
    Exp Eye Res; 1992 Apr; 54(4):611-9. PubMed ID: 1623946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early epithelial lesions in cataracts of GSH-depleted mouse pups.
    Laver NM; Robison WG; Calvin HI; Fu SC
    Exp Eye Res; 1993 Oct; 57(4):493-8. PubMed ID: 8282035
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics of buthionine sulfoximine (NSC 326231) and its effect on melphalan-induced toxicity in mice.
    Smith AC; Liao JT; Page JG; Wientjes MG; Grieshaber CK
    Cancer Res; 1989 Oct; 49(19):5385-91. PubMed ID: 2766304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced melphalan cytotoxicity following buthionine sulfoximine-mediated glutathione depletion in a human medulloblastoma xenograft in athymic mice.
    Skapek SX; Colvin OM; Griffith OW; Elion GB; Bigner DD; Friedman HS
    Cancer Res; 1988 May; 48(10):2764-7. PubMed ID: 3359437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of L-buthionine-[S,R]-sulfoximine on the pancreas in mice. A model of weakening glutathione-based defense mechanisms.
    Lüthen RE; Neuschwander-Tetri BA; Niederau C; Ferrell LD; Grendell JH
    Int J Pancreatol; 1994 Aug; 16(1):31-6. PubMed ID: 7528760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow.
    Ono K; Shrieve DC
    J Natl Cancer Inst; 1987 Oct; 79(4):811-5. PubMed ID: 3477662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cataractogenesis and lipid peroxidation in newborn rats treated with buthionine sulfoximine: preventive actions of melatonin.
    Li ZR; Reiter RJ; Fujimori O; Oh CS; Duan YP
    J Pineal Res; 1997 Apr; 22(3):117-23. PubMed ID: 9213264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.